Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Free Radic Biol Med. 2010 Mar 20;49(1):40–49. doi: 10.1016/j.freeradbiomed.2010.03.012

Table 2.

Percentage of G1 and S + G2 phases in MCF-10A cells replated from control and 4 d 4-Cl-BQ +/− PEG-CAT/PEG-SOD treated quiescent cells

Treat- ment(3μM) 0 h 18 h 26 h
Cell cycle phase G1 S + G2 G1 S + G2 G1 S + G2
Control 95 ± 1.9 5 ± 2.3 71 ± 2.2 29 ± 2.7 67 ± 3.2 33 ± 2.3
4-Cl-BQ 93 ± 1.7 7 ± 2.1 88 ± 2.8 *12 ± 2.5 87 ± 3.0 *13 ± 3.1
4-Cl-BQ + PEG 92 ± 0.9 8 ± 1.1 84 ± 1.3 *16 ± 1.9 82 ± 2.2 *18 ± 1.7
4-Cl-BQ + PEG-CAT 92 ± 2.1 8 ± 1.9 69 ± 2.3 31 ± 2.3 66 ± 3.6 34 ± 2.8
4-Cl-BQ + PEG-SOD 93 ± 1.8 7 ± 1.6 73 ± 3.5 27 ± 3.1 70 ± 3.6 30 ± 2.9
4-Cl-BQ + PEG- SOD/CAT 93 ± 2.4 7 ± 1.8 73 ± 2.9 27 ± 3.0 64 ± 2.8 36 ± 3.3

Average ± SD, n=3, p<0.05; Asterisks represent statistical significance relative to untreated control